Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Infovest21 study shows trend of more big names launching 40 Act funds

Thursday, July 18, 2013

Komfie Manalo, Opalesque Asia:

More multi-manager ’40 Act funds are being launched than single manager funds, and that trend is led by the large funds, according to a special report research by Infovest21, an information services company for the hedge fund industry based in New York.

Data from Infovest21 shows that large fund managers, including Blackstone, Pine Grove, Arden, Aurora, Permal, Russell, Neuberger Berman and Lazard have already launched products. Others that have filings pending include Entrust, Grosvenor and a KKR product with Prisma. The multi-manager products are varied and continue to evolve with the quality of managers improving, the release says.

Infovest notes, "When some of the large traditional asset management firms bought funds of funds in 2012, it was just a matter of time before they launched alt mutual funds. The acquisition of large funds of funds by mutual fund companies is a harbinger of those large firms launching liquid alt mutual funds. For example, Franklin Templeton acquired K2 in October 2012. Legg Mason's Permal Funds acquired Fauchier Partners in December 2012. Wells Fargo purchased a 35% stake in RockCreek in December 2012. KKR acquired a majority stake in Prisma Capital Partners in June 2012."

According to In......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its